Seminar Series
Seminar Series "Seminars in Lipid Signalling"
SFB 1039 Signalling by fatty acid derivatives and sphingolipids in health and disease
Haus 74, Seminarraum 4. OG, Raum 4.107 Universitätsklinikum Frankfurt, Goethe-Universität
| Date | Speaker | Topic |
|---|---|---|
| 18.09.2024 12 Uhr |
Holger Stark, PhD Univ.-Prof. Dr. Dr. h.c Pharmaceutical and Medicinal Chemistry, Heinrich-Heine-Universitaet Duesseldorf |
New pharmacological tools to modulate key elements in sphingolipide cascade |
| 18.09.2024 12 Uhr |
Dr. Gergely Gyimesi Department for BioMedical Research, University of Bern, Switzerland |
Structural basis of lipid recognition in solute carrier (SLC) lipid transporters |
| 07.03.2024 16 Uhr |
PD Dr. Florian Freudenberg Department of Psychiatry, Psychosomatics and Psychotherapy, Frankfurt |
Molecular Crossroads: Neuroinflammation, Lipid Signaling, and Their Impact on Mental Disorders |
| 05.03.2024 13 Uhr |
Prof. Stephan von Gunten Institut für Pharmakologie, Universität Bern, Schweiz |
The role of glycolipids and -proteins in inflammation and tumor immunology |
| 08.04.2020 15 Uhr |
Jerome Dejardin, PhD Institute of Human Genetics, University of Montpellier |
Locus-specific chromatin isolation |
| 04.03.2020 16 Uhr |
Patrick Niekamp Universität Osnabrück |
Sphingomyelin biosynthesis is essential for phagocytic signaling during mycobacteria host cell entry |
| 18.02.2020 12 Uhr |
Dr. Michaela Schedel National Jewish Health, University Duisburg-Essen |
Molecular and functional mechanisms contribute to the development of respiratory diseases |
| 05.02.2020 16 Uhr |
Prof. Dr. Dr. rer. nat. Dieter Lütjohann Universitätsklinikum Bonn |
Niemann-Pick disease type C - pathophysiology, diagnosis and therapy in human |
| 17.12.2019 12 Uhr |
Prof. Dr. med. Erich Gulbins Universität Duisburg-Essen |
Sphingolipids in pulmonary infections |
| 12.11.2019 12 Uhr |
Dr. Miroslav Machala Head, Department of Chemistry and Toxicology Veterinary Research Institute, Brno, Czech Republic |
Searching for candidates for novel lipidomic biomarkers in colon cancer-derived tissue samples |
| 24.09.2019 12 Uhr |
Prof. David Bishop-Bailey University of London |
A role for CYP450 derived lipids in inflammatory resolution? |
| 27.08.2019 12 Uhr |
Prof. Dr. Jürgen Seibel Universität Würzburg |
Exploring new frontiers of carbohydrate and lipid science: From chemical design to biological function |
| 25.06.2019 12 Uhr |
Jan Schlegel Universität Würzburg |
Super-resolution microscopy of sphingolipids in health and disease |
| 18.06.2019 12 Uhr |
Joost Holthuis, PhD Professor of Molecular Cell Biology University of Osnabrueck |
Dissecting protein-lipid crosstalk in life-death decision making with photo-actuated lipid probes |
| 14.05.2019 12 Uhr |
Prof. Ralph Witzgall University of Regensburg Institute for Molecular and Cellular Anatomy |
The ion-conducting properties of polycystin-2, a TRP channel mutated in autosomal-dominant polycystic kidney disease, determine the width and integrity of tubular structures in the kidney |
| 12.02.2019 12:30 Uhr |
Dr. Chris Thomas School of Pharmacy and Pharmaceutical Sciences Cardiff University |
Detection and characterisation of novel oxidised lipids from lipoxygenase enzymes |
| 11.12.2018 12 Uhr |
Professor Charles W. Frevert DVM, ScD University of Washington at South Lake Union |
Versican: A Key Immunomodulatory Molecule of the Innate Immune Response to Lung Infection |
| 04.12.2018 12 Uhr |
Dr. Volker Brinkmann Director & Distinguished Scientist a. D. Novartis Institutes for BioMedical Research Basel, Schweiz |
On the Molecular Medicine of Sphingolipids: Discovery and mechanisms of the Multiple Sclerosis Drug Fingolimod (Gilenya®) |
| 11.09.2018 12 Uhr |
Prof. Dr. Claudia Pellizas National University of Cordoba, Argentina |
Impact of Thyroid Hormones at the initiation of the immune response. Role in antitumor immunity |
| 07.08.2018 12 Uhr |
Professor Jun Zhu Icahn School of Medicine at Mount Sinai |
Integrative Network Analysis of Lipid Biosynthesis and Cell Response to Lipids |
| 10.07.2018 12 Uhr |
Dr. Norbert Tennagels Sanofi-Aventis Deutschland GmbH Biochemistry |
Revisiting Ceramide Signaling for Insulin Resistance Targeting |
| 26.06.2018 12 Uhr |
Prof. Dr. Dagmar Wachten University of Bonn, Institute of Innate Immunity |
Cellular functions of GlcCer and GBA2 |
| 12.06.2018 12 Uhr |
Dr. Kirstin Schilling INNOVECTIS GmbH |
Intellectual Property at University – How to patent and license research results |
| 29.05.2018 12 Uhr |
Prof. Dr. Peter Mattjus Abo Academy University, Turku, Finland |
Glycosphingolipids and their transfer proteins |
| 08.05.2018 12 Uhr |
Prof. Dr. Thorsten Hornemann Institute for Clinical Chemistry University Hospital Zurich |
No Brain No Pain - Headless Sphingolipids and Neuropathies |
| 02.05.2018 17 Uhr |
Prof. Dr. Hermann Eibel University Medical Center Freiburg Center for Chronic Immunodeficiency |
Mutations in CTLA-4 and JAK3 correlate with immunodysregulation |
| 26.04.2018 18 Uhr |
Prof. Dr. Hartmut Kühn Charité - Universitätsmedizin Berlin |
The patho-physiological role of leukotrienes and other eicosanoids in inflammatory diseases |
| 17.04.2018 12 Uhr |
Univ.-Prof. Dr. med. Mario Schiffer Medizinische Hochschule Hannover Klinik für Nieren- und Hochdruckerkrankungen |
The cytoskeleton of the podocyte: a translational treatment target option? |
| 06.02.2018 12 Uhr |
Prof. Dr. Dr. h. c. Dontscho Kerjaschki Medical University of Vienna |
The sentinel lymph node: a hub for metastatic tumor cell dissemination |
| 10.01.2018 12 Uhr |
Dr. rer. nat. Simone Reichelt-Wurm Universitätsklinik Regensburg |
Long non-coding RNAs in diabetic nephropathy |